Intellia Therapeutics Inc (FRA:38I)
€ 13.565 -0.175 (-1.27%) Market Cap: 1.44 Bil Enterprise Value: 903.64 Mil PE Ratio: 0 PB Ratio: 1.53 GF Score: 57/100

Q1 2021 Intellia Therapeutics Inc Earnings Call Transcript

May 06, 2021 / 12:00PM GMT
Release Date Price: €55.42 (-7.51%)
Operator

Good morning. My name is Eden, and I'll be your conference operator today. Welcome to the Intellia Therapeutics First Quarter 2021 Financial Results Conference Call. (Operator Instructions) This conference is being recorded at the company's request and will be available on the company's website following the end of the call.

I will now turn the conference over to Lina Li, Director of Investor Relations at Intellia. Please proceed.

Lina Li
Intellia Therapeutics, Inc. - Associate Director of IR

Thank you, operator, and good morning, everyone. Welcome to Intellia's First Quarter 2021 Earnings Call. Earlier today, the company issued a press release outlining the company's progress this quarter as well as topics for further discussion on today's call. This release can be found on the Investors & Media section of Intellia's website at intelliatx.com. This call is being broadcast live, and a replay will also be archived on the company's website.

At this time, I would like to take a minute to remind listeners that during this call, Intellia

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot